Andrej Sali
Corporate Officer/Principal bij The University of California, San Francisco
Profiel
Dr. Andrej Sali is Co-Founder at Global Blood Therapeutics, Inc. and a Professor at The University of California, San Francisco.
Dr. Sali was previously employed as an Associate Professor by The Rockefeller University and Founder by Prospect Genomix, Inc.
He received his undergraduate degree from the University of Ljubljana and a doctorate degree from the Birkbeck University of London.
Actieve functies van Andrej Sali
| Bedrijven | Functie | Begin |
|---|---|---|
| The University of California, San Francisco | Corporate Officer/Principal | - |
Eerdere bekende functies van Andrej Sali
| Bedrijven | Functie | Einde |
|---|---|---|
| The Rockefeller University | Corporate Officer/Principal | - |
| Prospect Genomix, Inc. | Oprichter | - |
| GLOBAL BLOOD THERAPEUTICS, INC. | Oprichter | - |
Opleiding van Andrej Sali
| University of Ljubljana | Undergraduate Degree |
| Birkbeck University of London | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
| Prospect Genomix, Inc. | |
Global Blood Therapeutics, Inc.
 Global Blood Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Global Blood Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders. It also provides oral medicines for sickle cell diseases. The company was founded by Matthew P. Jacobson, Andrej Sali, Jack Taunton, Charles J. Homcy, Craig D. Muir, and David R. Phillips in February 2011 and is headquartered in South San Francisco, CA. | Health Technology |
